Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer. [electronic resource]
Producer: 20120412Description: 231-3 p. digitalISSN:- 1651-226X
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.